Scholars@Duke
Judd Wendell Moul

Judd Wendell Moul

James H. Semans, M.D. Distinguished Professor of Urologic Surgery, in the School of Medicine
Urology
judd.moul@duke.edu
Box 3707 Med Ctr, Durham, NC 27710
1562 Blue Zone, Duke South, Durham, NC 27710
Office hours

Scholarly Works - Other

Editorial Comment.

Other Urology · January 2017 Full text Link to item Cite

Editorial Comment.

Other J Urol · September 2016 Full text Link to item Cite

Editorial

Other 3dtv Conference · August 22, 2016 Full text Cite

Editorial Comment.

Other Urology · July 2016 Full text Link to item Cite

Editorial Commentary.

Other Urol Pract · May 2016 Full text Link to item Cite

Editorial comment.

Other Urology · January 2016 Full text Link to item Cite

Editorial Comment.

Other Urology · October 2015 Full text Link to item Cite

Editorial comment.

Other Urology · May 2015 Full text Link to item Cite

Editorial comment.

Other Urology · January 2015 Full text Link to item Cite

Editorial.

Other Biomaterials · January 2015 Full text Link to item Cite

Reply: To PMID 25432832.

Other Urology · December 2014 Full text Link to item Cite

Editorial comment.

Other Urology · November 2014 Full text Link to item Cite

Editorial comment.

Other Urology · July 2014 Full text Link to item Cite

Reply

Other Urology · December 1, 2012 Full text Cite

What to order from the prostate cancer treatment menu?

Other Oncology (Williston Park) · January 2012 Link to item Cite

Maximizing outcomes in genitourinary cancers across the treatment continuum.

Other BJU Int · April 2011 Key controversies concerning the management of genitourinary cancers across the treatment continua were discussed at the second annual Interactive Genitourinary Cancer Conference (IGUCC) held in February 2010 in Athens, Greece. Prostate cancer is the most ... Full text Link to item Cite

Putting Provenge in perspective.

Other Oncology (Williston Park) · March 2011 Link to item Cite

Conclusion

Other Urology · January 1, 2011 Full text Cite

Editorial comment.

Other Urology · September 2010 Full text Link to item Cite

Reply

Other Urology · May 1, 2010 Full text Cite

Report from Durham.

Other Prostate Cancer Prostatic Dis · March 2010 Full text Link to item Cite

Editorial comment.

Other Urology · February 2010 Full text Link to item Cite

Reply

Other Urology · January 1, 2010 Full text Cite

Innovations in urology from military medicine.

Other Urol Oncol · 2009 Featured Publication Full text Link to item Cite

Report from Durham.

Other Prostate Cancer Prostatic Dis · 2009 Featured Publication Full text Link to item Cite

Are we overtreating prostate cancer?

Other J Urol · December 2008 Featured Publication Full text Link to item Cite

Rebuttal to Dr. Stock

Other Brachytherapy · October 1, 2008 Full text Cite

Carboplatin matches radiation in stage I seminoma: Commentary

Other Oncology Report · September 1, 2008 Cite

Report from Durham.

Other Prostate Cancer Prostatic Dis · 2008 Featured Publication Full text Link to item Cite

Report from Durham.

Other Prostate Cancer Prostatic Dis · 2008 Featured Publication Full text Link to item Cite

Report from Durham

Other Prostate Cancer and Prostatic Diseases · September 1, 2007 Full text Cite

Bevacizumab plus interferon-α improves survival: Commentary

Other Oncology Report · September 1, 2007 Cite

Follow-up after EBRT falls short of guideline: Commentary

Other Oncology Report · September 1, 2007 Cite

Adjuvant radiotherapy averts biochemical progression

Other Oncology Report · September 1, 2007 Cite

Report from Durham

Other Prostate Cancer and Prostatic Diseases · March 1, 2007 Full text Cite

PSA recurrence of prostate cancer: Update 2006

Other Consultant · December 1, 2006 Prostaste-specific antigen (PSA) recurrence is the most common form of advanced prostate cancer. Salvage therapies may be effective even among some high-risk men, although long-term cancer control data are limited The natural history of PSA recurrence is l ... Cite

The Eisenberger/Sinibaldi article reviewed

Other Oncology · December 1, 2006 Cite

Report from Durham

Other Prostate Cancer and Prostatic Diseases · September 1, 2006 Full text Cite

Prostate cancer

Other Current Opinion in Urology · May 1, 2006 Full text Cite

Editorial introduction

Other Current Opinion in Urology · May 1, 2006 Full text Cite

Report from Durham

Other Prostate Cancer and Prostatic Diseases · March 1, 2006 Full text Cite

Report from Durham

Other Prostate Cancer and Prostatic Diseases · September 1, 2005 Full text Cite

Untitled

Other CURRENT OPINION IN UROLOGY · May 1, 2005 Link to item Cite

In reply [2]

Other Journal of Clinical Oncology · February 20, 2005 Full text Cite

Report from Durham.

Other Prostate Cancer Prostatic Dis · 2005 Full text Link to item Cite

Prostate cancer

Other Current Opinion in Urology · January 1, 2005 Full text Cite

The Cooperberg/Park/Carroll article reviewed

Other Oncology · September 1, 2004 Cite

Editorial

Other Prostate Cancer and Prostatic Diseases · September 1, 2004 Full text Cite

Is the PSA test useless?

Other Prostate Cancer Prostatic Dis · 2004 Full text Link to item Cite

Editorial

Other Prostate Cancer and Prostatic Diseases · December 1, 2003 Full text Cite

PCPD editorial

Other Prostate Cancer and Prostatic Diseases · October 9, 2003 Full text Cite

PCPD editorial

Other Prostate Cancer and Prostatic Diseases · July 15, 2003 Full text Cite

Editorial

Other Prostate Cancer and Prostatic Diseases · January 1, 2003 Full text Cite

Leuprolide acetate: Viewpoints

Other American Journal of Cancer · January 1, 2003 Full text Cite

Editorial

Other Prostate Cancer and Prostatic Diseases · December 1, 2002 Full text Cite

Editorial

Other Prostate Cancer and Prostatic Diseases · January 1, 2002 Full text Cite

Editorial

Other Prostate Cancer and Prostatic Diseases · January 1, 2002 Full text Cite

Editorial

Other Prostate Cancer and Prostatic Diseases · January 1, 2002 Full text Cite

Editorial

Other Prostate Cancer and Prostatic Diseases · October 14, 2001 Full text Cite

Editorial

Other Prostate Cancer and Prostatic Diseases · July 24, 2001 Full text Cite

Editorial

Other Prostate Cancer and Prostatic Diseases · January 1, 2001 Full text Cite

Prostate imaging based on RF spectrum analysis and non-linear classifiers for guiding biopsies and targeting radiotherapy

Other Proceedings of SPIE the International Society for Optical Engineering · January 1, 2001 Conventional B-mode ultrasound is the standard means of imaging the prostate for guiding prostate biopsies and planning radiotherapy (i.e., brachytherapy and external-beam radiation) of prostate cancer (CaP). Yet B-mode images essentially do not allow visu ... Full text Cite

Probability of cancer detection with optimized prostate biopsy protocols

Other Proceedings of SPIE the International Society for Optical Engineering · January 1, 2001 What is the maximal possibility that a physician can detect a prostate cancer, given it is there? This research explores this issue from a statistical point of view and evaluates the theoretical results experimentally. We have collected 300 prostate specim ... Full text Cite

Prostate cancer and prostatic diseases: Editorial

Other Prostate Cancer and Prostatic Diseases · January 1, 2000 Full text Cite

Simulated prostate biopsy: Prostate cancer distribution and clinical correlation

Other Proceedings of SPIE the International Society for Optical Engineering · January 1, 2000 Our group has recently obtained data based upon whole-mounted step-sectioned radical prostatectomy specimens using a 3-D computer assisted prostate biopsy simulator that suggests an increased detection rate is possible using laterally placed biopsies. A ne ... Cite

Building an accurate 3D map of prostate cancer using computerized models of 280 whole-mounted radical prostatectomy specimens

Other Proceedings of SPIE the International Society for Optical Engineering · January 1, 2000 In order to develop optimized prostate needle biopsy protocols, we have investigated spatial distribution of prostate tumors using 3D prostate models developed from prostate specimens with localized cancer. An accurate zone-based algorithm has been propose ... Cite

Prostate and prostatic diseases: Editorial

Other Prostate Cancer and Prostatic Diseases · January 1, 2000 Full text Cite

Optimization of prostate biopsy

Other Proceedings of SPIE the International Society for Optical Engineering · January 1, 1999 Urologists routinely use the systematic sextant needle biopsy technique to detect prostate cancer. However, recent evidence suggests that this technique has a significant sampling error. We have developed a novel 3-D computer assisted prostate biopsy simul ... Full text Cite

Model supported virtual environment for prostate cancer pattern analysis

Other Proceedings of SPIE the International Society for Optical Engineering · January 1, 1999 A phased multidisciplinary research work was conducted to develop a master model supported image guidance in prostate biopsy, where a three-dimensional (3D) spatial probability maps of the location of high grade cancer will be constructed based on more tha ... Full text Cite

Frequency and location of benign prostatic glands in the surgical margin of 147 radical retropubic prostatectomies for carcinoma

Other British Journal of Urology · December 1, 1997 Introduction and Objectives : Three dimensional studies of whole mount total prostatectory specimens have revealed the presense of benign prostatic tissue as the surgical margins . The study was undertaken to evaluatte the frequqncy and location of benign ... Cite

Interactive three dimensional modeling of localized prostate cancer: Computer simulation of needle biopsy technique

Other British Journal of Urology · December 1, 1997 Introduction and Objectives: Ultrasound guided systematic sextant core needle biopsies of the prostate are commonly used for the detection of prostate cancer. The objective of this study is to evaluate the validity of adequate tumor sampling and tumor volu ... Cite

Prognostic risk factors in low stage nonseminumatous testicular germ cell tumors (NTGCT)

Other British Journal of Urology · December 1, 1997 Objective: Percentage of embryonal carcinoma (%EC) and vascular invasion are known risk factors to predict pathological stage II disease in clinical stage I NSGCT. Proliferation markers, cell cycle regulators, proteases and cell to cell adhesion molecules ... Cite

Apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer patients

Other British Journal of Urology · December 1, 1997 Background : Overexpression of both the mutant p53 and bcl-2 proteins in advanced prostate cancer (PC) has been impli-cated in hormone refractory disease and poor prognosis. p53 expression has been shown to be an independent prognostic marker for progressi ... Cite

The Powell Article Reviewed

Other Oncology · December 1, 1997 Cite

Epidemiology and screening for prostate cancer.

Other Am J Manag Care · August 1997 UNLABELLED: This activity is designed for primary care physicians, internists, and general audiences. GOAL: To provide the reader with a basic understanding of the controversy surrounding population-based prostate cancer screening and of the tools needed t ... Link to item Cite

Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer.

Other Cancer Res · January 15, 1994 We analyzed 92 clinical stage I nonseminomatous testicular germ cell tumors for primary tumor histological factors that would distinguish true pathological stage I disease (N = 54) from those patients who harbored occult disease and actually were later fou ... Link to item Cite

Active chemotherapy for metastatic stromal cell tumor of the testis.

Other Urology · December 1993 Metastatic stromal cell tumors of the testis are largely refractory to chemotherapy. We report a case of a young man with widely metastatic testicular stromal cell tumor who achieved complete clinical remission following chemotherapy with etoposide, ifosfa ... Full text Link to item Cite

Gangrene of the penis after implantation of penile prosthesis: case reports, treatment recommendations and review of the literature.

Other J Urol · July 1993 We report 3 cases of gangrene of the penis seen at our institution after penile prosthesis implantation. All 3 patients had insulin-dependent diabetes mellitus. Amputation was required in 2 patients. Aggressive debridement in conjunction with hyperbaric ox ... Full text Link to item Cite

Retroperitoneal lymphadenectomy.

Other Can J Surg · February 1993 Link to item Cite

Long-term results with vacuum constriction device.

Other J Urol · February 1993 From November 1985 to April 1990, 216 consecutive patients were treated with the vacuum constriction device. Patients were mailed an initial questionnaire (group 1) and a long-term questionnaire (group 2) at a median followup of 3 and 29 months, respective ... Full text Link to item Cite

Testicular tumour.

Other Br J Hosp Med · October 21, 1992 Link to item Cite

Inappropriate surgery for testicular cancer.

Other Br J Hosp Med · January 9, 1992 Link to item Cite

Preface

Other Oxford Art Journal · 1978 Full text Link to item Cite